They observed that the levels of receptor-binding-domain (RBD)-specific IgG and IgA slightly decreased between 6 and 10 weeks after the onset of COVID-19 symptoms and that RBD-specific IgM levels decreased much more abruptly (31). The gene discussed is CD79A; the disease is COVID-19.